|
|
||||||||
Journal of Lipid Research, Vol. 5, 548-553, October 1964
Copyright © 1964 by Lipid Research, Inc.
Department of Physiology, University of California, Berkeley, California
The incorporation of the C14 of glutamate-2-C14 and glutamate-5-C14 into fatty acids by epididymal fat pads and liver slices suggests the operation of the following metabolic pathway:
-ketoglutarate
isocitrate
cis-aconitate
citrate
acetyl CoA + oxalacetate (referred to as the backward reaction of the Krebs cycle).
Fatty acid-C14 recoveries from glutamate-2-C14, glutamate-5-C14, and acetate-1-C14 in experiments with epididymal fat pads from rats fed a stock diet were increased by the addition of glucose to the incubation medium, and further increased by in vitro addition of insulin. From these experiments it was calculated that, of the total amount of glutamate metabolized via the Krebs cycle, 6% proceeded by way of the backward reaction in the absence of glucose, 17% in the presence of glucose, and 35% when both glucose and insulin were added to the incubation medium. Fatty acid-C14 yields from glutamate-5-C14 and acetate-1-C14 were highest when the epididymal fat was taken from rats that had been fasted and then refed a 60% glucose diet. The in vitro addition of glucose or glucose plus insulin to the latter type of fat pad had no appreciable effect on the fatty acid-C14 yields.
Submitted on March 9, 1964
This article has been cited by other articles:
![]() |
M. A. Dominick, M. R. White, T. P. Sanderson, T. Van Vleet, S. M. Cohen, L. E. Arnold, M. Cano, S. Tannehill-Gregg, J. D. Moehlenkamp, C. R. Waites, et al. Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPAR {alpha}/{gamma} Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action Toxicol Pathol, December 1, 2006; 34(7): 903 - 920. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |